§ Paul FlynnTo ask the Secretary of State for Health if he will take steps to accelerate the process to allow the prescription of medicinal cannabis. [138354]
§ Dr. LadymanA marketing authorisation has not yet been issued for cannabis for pain relief use. The Medicines and Healthcare products Regulatory Agency will consider any application for a medicinal product containing cannabinoids for the treatment of spasticity and other symptoms related to multiple sclerosis.
Like any other medicinal product, however, cannabis-based medicines can only be granted a marketing authorisation for medical purposes when supporting data have been submitted to demonstrate that the quality, safety and efficacy of the product are satisfactory for the intended use.